Barteczko, Manoela Linhares Machado http://orcid.org/0000-0003-3226-5831
Orellana, Henry Campos http://orcid.org/0000-0001-9454-3871
Santos, Gustavo Rocha Feitosa http://orcid.org/0000-0002-2403-9589
Galhardo, Attílio http://orcid.org/0000-0002-8340-7302
Kanhouche, Gabriel http://orcid.org/0000-0002-1133-0465
Faccinetto, Ana Carolina Buso http://orcid.org/0000-0002-5434-770X
Júnior, Hélio Tedesco http://orcid.org/0000-0002-9896-323X
Pestana, José Osmar Medina http://orcid.org/0000-0002-0750-7360
de Paola, Ângelo Amato Vincenzo http://orcid.org/0000-0001-9101-3170
Barbosa, Adriano Henrique Pereira http://orcid.org/0000-0001-6936-9162
Article History
Received: 2 April 2021
Accepted: 1 February 2022
First Online: 8 February 2022
Declarations
:
: The Ethics Committee of the Federal University of São Paulo (UNIFESP) approved this study (reference number 4.098.877). This study was conducted in accordance with Good Clinical Practice, EU guidelines (EN 540), local regulations and the Helsinki Declaration. All medical ethics rules were followed throughout the research. The need for informed consent was waived by the Ethics Committee of the Federal University of São Paulo (UNIFESP).
: Not applicable
: Hélio Tedesco Silva Júnior has received research grants and travel and consulting honouraria from Novartis, Sanofi and Pfizer. The remaining authors have no competing interests to disclose.